Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance Priya BahriGeoffrey BowringJanet Sultana FROM THE ISoP 23 May 2023 Pages: 517 - 532
Impact of Lifestyle and Socioeconomic Position on the Association Between Non-steroidal Anti-inflammatory Drug Use and Major Adverse Cardiovascular Events: A Case-Crossover Study Kasper BonnesenLars PedersenMorten Schmidt Original Research Article Open access 02 May 2023 Pages: 533 - 543
Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase) Takahiro NiimuraKoji MiyataKeisuke Ishizawa Original Research Article 27 April 2023 Pages: 545 - 552
Long-Term Safety Analysis of the ChAdOx1-nCoV-19 Corona Virus Vaccine: Results from a Prospective Observational Study in Priority Vaccinated Groups in North India Upinder KaurZeba FatimaSankha Shubhra Chakrabarti Original Research Article 03 May 2023 Pages: 553 - 563
Facilitators and Barriers to Uptake of the Med Safety Mobile App for Adverse Drug Reaction Reporting by Health Workers in Uganda: A Qualitative Study Ronald KigubaHenry ZakumumpaMunir Pirmohamed Original Research Article Open access 25 April 2023 Pages: 565 - 574
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials Fariba AhmadizarNicoletta LuxiilmiovaccinoCOVID19 collaborating group Original Research Article Open access 27 April 2023 Pages: 575 - 585
The Effect of Metformin on Chemotherapy-Induced Toxicities in Non-diabetic Breast Cancer Patients: A Randomised Controlled Study Manar A. SerageldinAmira B. KassemNoha A. El-Bassiouny Original Research Article Open access 02 May 2023 Pages: 587 - 599
Identifying Safety Subgroups at Risk: Assessing the Agreement Between Statistical Alerting and Patient Subgroup Risk Olivia MahauxGreg PowellAndrew Bate Original Research Article Open access 02 May 2023 Pages: 601 - 614
Comment on: "Should Antidepressants be Avoided in Pregnancy?" Alain BraillonSusan BewleyFlorian Naudet Letter to the Editor 27 April 2023 Pages: 615 - 616
Authors’ Reply to Braillon et al. ’s Comment on “Should Antidepressants be Avoided in Pregnancy?” Frank M. C. BesagMichael J. Vasey Letter to the Editor 27 April 2023 Pages: 617 - 618